Global DEB, Microcatheters and Radiopaque Beads Market US$ 12.2 Billion by 2021

Global DEB, Microcatheters and Radiopaque Beads Market US$ 12.2 Billion by 2021

The global drug eluting beads, microcatheters and radiopaque beads in interventional oncology market is estimated to reach nearly US$ 12.2 Billion in 2021, expanding at a CAGR of 8.6% from 2017 to 2021.

Browse Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market by Geography North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World and Forecast 2017-2021 at https://www.ihealthcareanalyst.com/report/drug-eluting-beads-microcatheters-radiopaque-beads-interventional-oncology-market/

Drug-eluting bead transarterial chemoembolization (DEB-TACE) allows for embolization as well as local release of chemotherapy in the treatment of hepatic malignancy, providing an alternative therapeutic option in unresectable tumours. Drug-eluting bead TACE is becoming more widely utilized in primary and liver-dominant metastatic disease of the liver. Microcatheters are employed extensively in the neurovascular and cardiovascular fields and are ideal for navigating the vast network of tiny veins found within the body. Radiopaque beads provide better conspicuity in determining the target during embolization and also allow optimal balance and delivery performance, as well real time display of embolic material or drug delivery.

The global drug eluting beads, microcatheters and radiopaque beads in interventional oncology market report estimates the market size (Revenue US$ million – 2014 to 2021) by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World and forecasts growth trends (CAGR% – 2017 to 2021).

Major players operating the global drug eluting beads, microcatheters and radiopaque beads in interventional oncology market and profiled in this report include Abbott Laboratories (Abbott EP), ABK Biomedical, Inc., Boston Scientific Corporation, BTG plc, Cook Medical, Inc., Medtronic, Inc., Merit Medical Systems, Inc., Stryker Corporation, Surefire Medical, Inc., Terumo Corporation, and Vascular Solutions, Inc.

To request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/drug-eluting-beads-microcatheters-radiopaque-beads-interventional-oncology-market/

2017-11-01T10:46:55+00:00 Categories: Press Releases|